SS
Sandhya Sanjay Gorana
About Sandhya Sanjay Gorana
Data last updated:
Sandhya Sanjay Gorana is a Director at Medin Healthcare Private Limited (since 2018), Designated Partner at Zenshin Life Sciences Llp (since 2025) and Designated Partner at Zenshin Pharmatek Llp (since 2022). The companies operate in Healthcare and Paper. The largest current company by reported revenue is Medin Healthcare Private Limited at ₹18,291 (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Aug 2018 | 2018 | ₹18,291 (FY 2020) | Active | |
| Designated Partner | 17 Nov 2025 | 2025 | Active | ||
| Designated Partner | 10 Nov 2022 | 2022 | Active |
Board colleagues of Sandhya Sanjay Gorana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Snigdha Gorana | 08192640 | Medin Healthcare Private Limited | Director |
| Sanjay Govind Lal Gorana | 09184456 | Zenshin Life Sciences Llp , Zenshin Pharmatek Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandhya Sanjay Gorana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandhya Sanjay Gorana
Sandhya Sanjay Gorana currently holds 3 directorships: Medin Healthcare Private Limited (Director, since 03 Aug 2018, revenue ₹18,291 (FY 2020)); Zenshin Life Sciences Llp (Designated Partner, since 17 Nov 2025); Zenshin Pharmatek Llp (Designated Partner, since 10 Nov 2022).
Sandhya Sanjay Gorana was first appointed on 03 Aug 2018 as Director at Medin Healthcare Private Limited. The most recent appointment on record is 17 Nov 2025 at Zenshin Life Sciences Llp.
The current boards of Sandhya Sanjay Gorana's companies include Snigdha Gorana (Medin Healthcare Private Limited), Sanjay Govind Lal Gorana (Zenshin Life Sciences Llp).